Browsed by
Tag: united

United States A2P and P2A Messaging Market Size is Projected to Reach USD 18,737.19 Million by 2025 | Valuates Reports

United States A2P and P2A Messaging Market Size is Projected to Reach USD 18,737.19 Million by 2025 | Valuates Reports

BANGALORE, India, Oct. 12, 2020 /PRNewswire/ — According to the Latest Market Research Report “A2P & P2A Messaging Market by Type (A2P, P2A), by Traffic (Multi-Country, National), by Messaging Platform (Cloud API Messaging Platform, Traditional & Managed Messaging Platform), by Industry (Aerospace & Defense, Automotive & Transportation, Banking, Financial Services & Insurance, Building, Construction & Real Estate, Education, Consumer Goods & Retail, Energy & Utilities, Government & Public Sector, Healthcare & Life Sciences, Information Technology, Manufacturing, Media & Entertainment, Telecommunication, and Travel & Hospitality), by Application (Authentication Services, Customer Relationship Management Services, Inquiry & Search Related Services, Interactive Messages, Notifications & Alerts, Promotional & Marketing Services, Pushed Content Services, Voting & Entertainment),  and Region – Global Forecast to 2025“, published on Valuates Reports. 

Valuates_Reports_Logo

The United States A2P & P2A Messaging Market is expected to grow from USD 14,378.29 Million in 2019 to USD 18,737.19 Million by 2025 at a CAGR of 4.51%.

Major factors driving the growth of Application to Person (A2P) & Person to Application (P2A) Messaging Market size include increased mobile marketing by advertisers and application developers, innovations in mobile payment and mobile banking apps, the ability to access messages without internet connexion, and the rapid growth in the mobile user base.

The report provides an exhaustive assessment of A2P & P2A Messaging Market size, shares, strategies, products, and manufacturing capabilities of the leading players. It also offers in-depth information about lucrative emerging markets, new product launches, untapped geographies, recent developments, and investments.

Get Detailed Analysis of COVID-19 Impact on A2P & P2A Messaging Market: https://reports.valuates.com/request/sample/360I-Auto-4J402/A2P_P2A_Messaging

TRENDS INFLUENCING THE A2P & P2A MESSAGING MARKET

Interaction and engagement with consumers have become important for businesses in the current market scenario. This, in turn, has boosted the growth of the A2P & P2A Messaging Market size.

Due

Read the rest
United States A2P and P2A Messaging Market Size is Projected to Reach USD 18,737.19 Million by 2025

United States A2P and P2A Messaging Market Size is Projected to Reach USD 18,737.19 Million by 2025

BANGALORE, India, Oct. 12, 2020 /PRNewswire/ — According to the Latest Market Research Report “A2P & P2A Messaging Market by Type (A2P, P2A), by Traffic (Multi-Country, National), by Messaging Platform (Cloud API Messaging Platform, Traditional & Managed Messaging Platform), by Industry (Aerospace & Defense, Automotive & Transportation, Banking, Financial Services & Insurance, Building, Construction & Real Estate, Education, Consumer Goods & Retail, Energy & Utilities, Government & Public Sector, Healthcare & Life Sciences, Information Technology, Manufacturing, Media & Entertainment, Telecommunication, and Travel & Hospitality), by Application (Authentication Services, Customer Relationship Management Services, Inquiry & Search Related Services, Interactive Messages, Notifications & Alerts, Promotional & Marketing Services, Pushed Content Services, Voting & Entertainment),  and Region – Global Forecast to 2025“, published on Valuates Reports. 

The United States A2P & P2A Messaging Market is expected to grow from USD 14,378.29 Million in 2019 to USD 18,737.19 Million by 2025 at a CAGR of 4.51%.

Major factors driving the growth of Application to Person (A2P) & Person to Application (P2A) Messaging Market size include increased mobile marketing by advertisers and application developers, innovations in mobile payment and mobile banking apps, the ability to access messages without internet connexion, and the rapid growth in the mobile user base.

The report provides an exhaustive assessment of A2P & P2A Messaging Market size, shares, strategies, products, and manufacturing capabilities of the leading players. It also offers in-depth information about lucrative emerging markets, new product launches, untapped geographies, recent developments, and investments.

Get Detailed Analysis of COVID-19 Impact on A2P & P2A Messaging Market: https://reports.valuates.com/request/sample/360I-Auto-4J402/A2P_P2A_Messaging

TRENDS INFLUENCING THE A2P & P2A MESSAGING MARKET

Interaction and engagement with consumers have become important for businesses in the current market scenario. This, in turn, has boosted the growth of the A2P & P2A Messaging Market size.

Due

Read the rest
Arena Pharmaceuticals’ Presence at United European Gastroenterology Week Strengthens Ongoing Commitment to the Gastrointestinal Disease Community

Arena Pharmaceuticals’ Presence at United European Gastroenterology Week Strengthens Ongoing Commitment to the Gastrointestinal Disease Community

SAN DIEGO, Oct. 9, 2020 /PRNewswire/ — Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) will present new data from the Phase 2 OASIS trial and its open-label extension for its investigative drug candidate etrasimod, a next-generation, once-daily, oral, highly selective sphingosine 1-phosphate (S1P) receptor modulator, in patients with moderately to severely active ulcerative colitis (UC) at the 26th Annual United European Gastroenterology (UEG) Week. Arena will also present preclinical data for olorinab, a peripherally acting, highly selective, full agonist of the cannabinoid receptor 2 (CB2), in development for the treatment of visceral pain in gastrointestinal (GI) diseases. UEG Week is taking place virtually October 11-13, 2020.

Arena Sponsored Symposium Details: 
Title: Opening the Door to Emerging Investigational Treatments in Ulcerative Colitis: What Awaits Us?
Intended Audience: This symposium is designed for non-US healthcare professionals and is not affiliated with UEGW
Speakers: William Sandborn, MD (Chair), Professor Silvio Danese, Remo Panaccione, MD, FRCPC
Day/Time: Monday, October 12 at 17:30 CET

Presentation Details:
Title: Early and Durable Symptom Control in Patients with Moderately to Severely Active Ulcerative Colitis Treated with Etrasimod in the Randomised, Double Blind, Placebo Controlled, Phase 2 OASIS Trial and Open Label Extension
Day/Time: Tuesday, October 13, 2020, from 15:00-16:00 CET
ePoster: P0481

Title: Expression of Cannabinoid Receptors and the Effect of Olorinab, a Peripherally Acting, Highly Selective, Full Agonist of the Cannabinoid Receptor 2, on Visceral Hypersensitivity in Rodent Models of Irritable Bowel Syndrome and Inflammatory Bowel Disease 
Day/Time: Sunday, October 11, 2020, 18:00-19:00 CET    
Oral presentation: OP058    

Title: The Incremental Increasing Rate of Thromboembolic Events in Patients with Inflammatory Bowel Disease Compared to Patients Without Autoimmune Disorder   
Event: Virtual poster exhibition
ePoster: P0377                    

About Etrasimod
Etrasimod (APD334) is a once-daily, oral, highly selective sphingosine 1-phosphate (S1P) receptor modulator, discovered by Arena, designed

Read the rest